News

As Juniper Networks (JNPR) Share Value Declined, Employees Retirement System Of Texas Has Increased by $406,000 Its Stake; As Teva Pharmaceutical Inds LTD (TEVA) Stock Value Declined, Mivtachim The Workers Social Insurance Fund LTD Has Raised by $5.04 Million Its Position

[ad_1]

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Logo

Employees Retirement System Of Texas increased its stake in Juniper Networks Inc (JNPR) by 46.67% based on its latest 2018Q3 regulatory filing with the SEC. Employees Retirement System Of Texas bought 14,000 shares as the company’s stock declined 0.07% with the market. The institutional investor held 44,000 shares of the technology company at the end of 2018Q3, valued at $1.32M, up from 30,000 at the end of the previous reported quarter. Employees Retirement System Of Texas who had been investing in Juniper Networks Inc for a number of months, seems to be bullish on the $9.80 billion market cap company. The stock increased 0.71% or $0.2 during the last trading session, reaching $28.38. About 2.28 million shares traded. Juniper Networks, Inc. (NYSE:JNPR) has declined 2.85% since January 26, 2018 and is downtrending. It has underperformed by 2.85% the S&P500. Some Historical JNPR News: 22/04/2018 – DJ Juniper Networks Inc, Inst Holders, 1Q 2018 (JNPR); 01/05/2018 – Juniper Networks 1Q Rev $1.08B; 18/04/2018 – Juniper Closes Below 50-Day Moving Average: Technicals; 24/05/2018 – MEDIA ALERT: Juniper Networks Discusses Today’s Security Landscape at lnfosec 2018; 10/04/2018 – Juniper Research: Mixed Reality Apps to Exceed 9 billion by 2022, as Industry aims to Emulate Pokémon Go’s Success; 17/04/2018 – Juniper Presenting at RSA Conference Tomorrow; 14/05/2018 – Juniper Presenting at Bank of America Conference Jun 5; 17/05/2018 – Culture In Tech: Shifts At VMWare And Juniper Signal Diverging Paths; Investigation At Symantec Highlights Importance Of Compliance Culture; 21/03/2018 – Juniper Research: Online Lottery Wagers to More than Double, Reaching $76 Billion by 2022, as Mobile Drives Demand; 23/03/2018 – JUNIPER NETWORKS NAMES MANOJ LEELANIVAS CHIEF PRODUCT OFFICER

Mivtachim The Workers Social Insurance Fund Ltd increased its stake in Teva Pharmaceutical Inds Ltd (TEVA) by 27% based on its latest 2018Q3 regulatory filing with the SEC. Mivtachim The Workers Social Insurance Fund Ltd bought 240,000 shares as the company’s stock declined 12.44% with the market. The institutional investor held 1.13M shares of the major pharmaceuticals company at the end of 2018Q3, valued at $24.32 million, up from 888,926 at the end of the previous reported quarter. Mivtachim The Workers Social Insurance Fund Ltd who had been investing in Teva Pharmaceutical Inds Ltd for a number of months, seems to be bullish on the $21.31 billion market cap company. The stock increased 1.14% or $0.22 during the last trading session, reaching $19.56. About 7.39M shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has risen 22.93% since January 26, 2018 and is uptrending. It has outperformed by 22.93% the S&P500. Some Historical TEVA News: 13/03/2018 – #3 Teva calls off CGRP drug discovery and development pact, returns preclinical asset to Sosei @AmberTongPW; 03/05/2018 – TEVA – REGARDING FREMANEZUMAB, CO SEES FDA PRE-APPROVAL INSPECTION TO TAKE PLACE IN COMING MONTHS & TO RECEIVE FDA APPROVAL & LAUNCH BEFORE 2018 END; 03/04/2018 – KC Bus Journal: Teva sells OP business segment; 10/05/2018 – TEVA CANADA REPORTS LAUNCH OF TEVA-CYCLOSPORINE® OPHTHALMIC EMU; 10/04/2018 – Mylan to Acquire the Global Marketing Rights to a Once-monthly Glatiramer Acetate Pdt Through an Investment and Partnership With Israeli Co Mapi Pharma; 27/04/2018 – TEVA PHARMACEUTICAL INDUSTRIES LTD – ADVERSE EVENTS WERE GENERALLY MILD AND CONSISTENT WITH WELL-ESTABLISHED SAFETY PROFILE OF COPAXONE; 02/05/2018 – Teva to Present AUSTEDO® (deutetrabenazine) Tablets Data at the American Psychiatric Association 2018 Annual Meeting; 03/05/2018 – TEVA PHARMACEUTICAL INDUSTRIES LTD – RAISING 2018 FULL YEAR GUIDANCE; 28/03/2018 – NJ WARN NOTICES ISSUED FOR JOB CUTS AT TEVA PLANT IN ELIZABETH; 26/03/2018 – ADHERIUM – U.S. FDA GRANTED 510(K) CLEARANCE FOR OVER THE COUNTER SALE OF SMARTINHALERTM SENSOR FOR ASTRAZENECA’S SYMBICORT AEROSOL ASTHMA INHALER

More notable recent Teva Pharmaceutical Industries Limited (NYSE:TEVA) news were published by: Seekingalpha.com which released: “UBS likes Lilly in premarket analyst action – Seeking Alpha” on January 23, 2019, also Seekingalpha.com with their article: “Teva continues selloff, down 5% – Seeking Alpha” published on September 26, 2018, Seekingalpha.com published: “Teva up 3% premarket on bullish call at UBS – Seeking Alpha” on January 23, 2019. More interesting news about Teva Pharmaceutical Industries Limited (NYSE:TEVA) were released by: 247Wallst.com and their article: “Teva and Amgen Settle Over Kidney Disease Patent Infringement – 24/7 Wall St.” published on January 03, 2019 as well as Seekingalpha.com‘s news article titled: “Teva: Great Investment With An Upside Even In Volatile Markets – Seeking Alpha” with publication date: December 21, 2018.

Among 35 analysts covering Teva Pharma (NYSE:TEVA), 9 have Buy rating, 4 Sell and 22 Hold. Therefore 26% are positive. Teva Pharma had 172 analyst reports since July 21, 2015 according to SRatingsIntel. On Wednesday, January 4 the stock rating was maintained by Maxim Group with “Buy”. The company was maintained on Thursday, February 15 by Mizuho. The firm earned “Underperform” rating on Friday, November 3 by RBC Capital Markets. Oppenheimer maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Wednesday, October 4 with “Hold” rating. As per Friday, December 22, the company rating was upgraded by Cantor Fitzgerald. Wells Fargo downgraded Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Friday, January 5 to “Underperform” rating. Argus Research maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Tuesday, July 28 with “Buy” rating. Barclays Capital maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) rating on Monday, August 7. Barclays Capital has “Equal-Weight” rating and $23 target. Cantor Fitzgerald initiated the stock with “Neutral” rating in Friday, June 16 report. The rating was maintained by Morgan Stanley on Friday, August 3 with “Equal-Weight”.

Mivtachim The Workers Social Insurance Fund Ltd, which manages about $1.71 billion US Long portfolio, decreased its stake in Opko Health Inc (NYSE:OPK) by 500,000 shares to 1.26M shares, valued at $4.36M in 2018Q3, according to the filing.

Since August 22, 2018, it had 0 buys, and 4 insider sales for $4.71 million activity. Athreya Anand also sold $3.36M worth of Juniper Networks, Inc. (NYSE:JNPR) shares. 16,100 shares were sold by rahim rami, worth $488,676.

Among 36 analysts covering Juniper Networks Inc. (NYSE:JNPR), 9 have Buy rating, 8 Sell and 19 Hold. Therefore 25% are positive. Juniper Networks Inc. had 108 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of Juniper Networks, Inc. (NYSE:JNPR) has “Outperform” rating given on Wednesday, December 7 by Credit Suisse. Nomura downgraded it to “Hold” rating and $27.0 target in Thursday, October 12 report. The rating was maintained by UBS on Wednesday, October 25 with “Neutral”. The rating was initiated by J.P. Morgan with “Sell” on Thursday, May 3. The company was maintained on Wednesday, January 31 by Barclays Capital. RBC Capital Markets maintained Juniper Networks, Inc. (NYSE:JNPR) rating on Tuesday, June 27. RBC Capital Markets has “Hold” rating and $3000 target. The rating was maintained by Needham with “Hold” on Thursday, October 12. The firm has “Hold” rating by Bank of America given on Wednesday, October 11. The stock of Juniper Networks, Inc. (NYSE:JNPR) earned “Buy” rating by BMO Capital Markets on Wednesday, August 23. The stock of Juniper Networks, Inc. (NYSE:JNPR) earned “Buy” rating by Standpoint Research on Tuesday, February 27.

More notable recent Juniper Networks, Inc. (NYSE:JNPR) news were published by: Globenewswire.com which released: “Juniper Networks Announces Intent to Acquire HTBASE – GlobeNewswire” on November 29, 2018, also Seekingalpha.com with their article: “Juniper Networks +2.3% as Nomura steps to Buy – Seeking Alpha” published on September 19, 2018, Seekingalpha.com published: “Juniper: On The Sidelines For Now – Seeking Alpha” on October 28, 2018. More interesting news about Juniper Networks, Inc. (NYSE:JNPR) were released by: Globenewswire.com and their article: “Juniper Networks Reports Preliminary Third Quarter 2018 Financial Results – GlobeNewswire” published on October 23, 2018 as well as Globenewswire.com‘s news article titled: “Juniper Networks Hosts Annual User Conference NXTWORK 2018 Americas – GlobeNewswire” with publication date: October 09, 2018.

Juniper Networks, Inc. (NYSE:JNPR) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.



[ad_2]

Source link